FOXBOROUGH, Mass. & NEW YORK--(BUSINESS WIRE)--March 28, 2006--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN: “Cyberkinetics”), and Columbia University Medical Center (“Columbia”) have entered into a collaborative agreement to evaluate the utility of brain electrical activity recordings obtained using Cyberkinetics’ NeuroPort(TM) Neural Monitoring System (“NeuroPort System”). Columbia intends to use the NeuroPort System to improve the understanding of certain abnormal human brain processes, which may include those commonly associated with epileptic seizures, Parkinson’s disease and other movement disorders, as well as many other neurological diseases. As part of the agreement, Cyberkinetics has an option to license any inventions derived from the research collaboration.
